Rantakari Pia, Patten Daniel A, Valtonen Joona, Karikoski Marika, Gerke Heidi, Dawes Harriet, Laurila Juha, Ohlmeier Steffen, Elima Kati, Hübscher Stefan G, Weston Chris J, Jalkanen Sirpa, Adams David H, Salmi Marko, Shetty Shishir
MediCity Research Laboratory and Department of Medical Microbiology and Immunology, University of Turku, FI-20520, Turku, Finland;
National Institute for Health Research Birmingham Liver Biomedical Research Unit and Centre for Liver Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, United Kingdom;
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9298-303. doi: 10.1073/pnas.1604780113. Epub 2016 Jul 29.
Macrophages are key regulators of fibrosis development and resolution. Elucidating the mechanisms by which they mediate this process is crucial for establishing their therapeutic potential. Here, we use experimental models of liver fibrosis to show that deficiency of the scavenger receptor, stabilin-1, exacerbates fibrosis and delays resolution during the recovery phase. We detected a subset of stabilin-1(+) macrophages that were induced at sites of cellular injury close to the hepatic scar in mouse models of liver fibrosis and in human liver disease. Stabilin-1 deficiency abrogated malondialdehyde-LDL (MDA-LDL) uptake by hepatic macrophages and was associated with excess collagen III deposition. Mechanistically, the lack of stabilin-1 led to elevated intrahepatic levels of the profibrogenic chemokine CCL3 and an increase in GFAP(+) fibrogenic cells. Stabilin-1(-/-) macrophages demonstrated a proinflammatory phenotype during liver injury and the normal induction of Ly6C(lo) monocytes during resolution was absent in stabilin-1 knockouts leading to persistence of fibrosis. Human stabilin-1(+) monocytes efficiently internalized MDA-LDL and this suppressed their ability to secrete CCL3, suggesting that loss of stabilin-1 removes a brake to CCL3 secretion. Experiments with cell-lineage-specific knockouts revealed that stabilin-1 expression in myeloid cells is required for the induction of this subset of macrophages and that increased fibrosis occurs in their absence. This study demonstrates a previously unidentified regulatory pathway in fibrogenesis in which a macrophage scavenger receptor protects against organ fibrosis by removing fibrogenic products of lipid peroxidation. Thus, stabilin-1(+) macrophages shape the tissue microenvironment during liver injury and healing.
巨噬细胞是纤维化发展和消退的关键调节因子。阐明它们介导这一过程的机制对于确定其治疗潜力至关重要。在这里,我们使用肝纤维化实验模型表明,清道夫受体stabilin-1的缺乏会加剧纤维化,并在恢复阶段延迟消退。我们在肝纤维化小鼠模型和人类肝脏疾病中检测到在靠近肝瘢痕的细胞损伤部位诱导产生的stabilin-1(+)巨噬细胞亚群。Stabilin-1缺乏消除了肝巨噬细胞对丙二醛修饰低密度脂蛋白(MDA-LDL)的摄取,并与过量的III型胶原蛋白沉积有关。从机制上讲,stabilin-1的缺乏导致肝内促纤维化趋化因子CCL3水平升高,以及GFAP(+)纤维化细胞增加。在肝损伤期间,Stabilin-1(-/-)巨噬细胞表现出促炎表型,在消退过程中正常诱导的Ly6C(lo)单核细胞在stabilin-1基因敲除小鼠中不存在,导致纤维化持续存在。人类stabilin-1(+)单核细胞有效地内化MDA-LDL,这抑制了它们分泌CCL3的能力,表明stabilin-1的缺失消除了对CCL3分泌的抑制。细胞谱系特异性基因敲除实验表明,骨髓细胞中stabilin-1的表达是诱导这一巨噬细胞亚群所必需的,在其缺失时会发生纤维化增加。这项研究揭示了纤维化形成过程中一条以前未被识别的调节途径,其中巨噬细胞清道夫受体通过清除脂质过氧化的纤维化产物来预防器官纤维化。因此,stabilin-1(+)巨噬细胞在肝损伤和愈合过程中塑造了组织微环境。